Heart Rhythm 2008 San Francisco May 15, 2008 Stephen Hammill, MD Heart Rhythm 2008 San Francisco May 15, 2008 Stephen Hammill, MD CP1262561-1 Using the.

Slides:



Advertisements
Similar presentations
WPA-WHO Global Survey of Psychiatrists' Attitudes Towards Mental Disorders Classification Results for the Spanish Society of Psychiatry.
Advertisements

Agenda Introduction Classes of recommendations Level of evidence
ACTION Registry (Acute Coronary Treatment and Intervention Outcomes Network) Initial Report 1st Quarter 2007 Results Report prepared by: www. ncdr.com.
Alabama Primary Health Care Association
Prevalence and Predictors of Off-label Use of Cardiac Resynchronization Therapy: A Report from the ICD Registry TM Adam S. Fein * MD, Yongfei Wang ¥ MS,
Prepared by: ACTION Registry-GWTG Results: January – December, 2008.
Ten years of the CHD NSF Professor Roger Boyle CBE National Director for Heart Disease and Stroke Department of Health.
Building a New Payment System: Stakeholder Perspectives on Principles and Elements Robert L. Broadway, FHFMA VP of Corporate Strategy, Bethesda Healthcare.
Government P4P Programs: Pay for Performance - Is Medicare a Good Candidate? Albert W. Morris, Jr., M.D. President National Medical Association The Second.
June 20, 2008 Alliance for Health Reform Janet Wright MD FACC IC 3 Program: Challenges, Lessons, and Hope.
Medicare Prescription Drug Benefit Progress Report: Findings from the Kaiser/Commonwealth/Tufts-New England Medical Center 2006 National Survey of Seniors.
1 Physicians Involved in the Care of Patients with Recently Diagnosed Cancer CanCORS Provider Composition Writing Group Academy Health Annual Research.
NTDB ® Annual Report 2009 © American College of Surgeons All Rights Reserved Worldwide Percent of Hospitals Submitting Data to NTDB by State and.
NTDB ® Annual Report 2010 © American College of Surgeons All Rights Reserved Worldwide National Trauma Data Bank 2010 Annual Report.
Update on Recent Health Reform Activities in Minnesota.
Multicenter Automatic Defibrillator Implantation Trial II
Overview of Rural Health Care Ethics Training materials from Rural Health Care Ethics: A Manual for Trainers. WA Nelson and KE Schifferdecker, Dartmouth.
The basics for simulations
Introduction Discussion Results Mobile Health Clinics are transportable health care units that deliver high-value community based health care to underserved.
1 Sex/Gender and Minority Inclusion in NIH Clinical Research What Investigators Need to Know!
Cardiac Insufficiency Bisoprolol Study (CIBIS III) Trial
THE COMMONWEALTH FUND Figure 1. Nine of 10 Health Care Opinion Leaders Think Fundamental Change Is Required to Achieve Gains in Quality and Efficiency.
PROCESS vs. WA State SCS Study A Comparison of Study Design, Patient Population, and Outcomes August 29,2007.
CMR of Non-ischemic Dilated and Restrictive Cardiomyopathies
Slide 1 The Mountain-Pacific DOQ-IT Project. Slide 2 Overview What is the DOQ-IT Project? Mountain-Pacific’s progress in DOQ-IT Mountain-Pacific’s perspective.
Cardiac Resynchronization Heart Failure Study Cardiac Resynchronization Heart Failure Study Presented at American College of Cardiology Scientific Sessions.
Improving Office Care for Chest Pain Thomas D. Sequist, MD MPH Associate Professor of Medicine and Health Care Policy Brigham and Women ’ s Hospital, Division.
Ron D. Hays, Ph.D. Alex Y. Chen, M.D. UCLA Children’s Hospital LA
1 Costs and Rehabilitation of Stroke Patients: A Retrospective Study of Medicare Beneficiaries Richard D. Zorowitz, MD 1 ; Er Chen, MPP 2 ; Kuo B. Tong,
Preventable Hospitalizations: Assessing Access and the Performance of Local Safety Net Presented by Yu Fang (Frances) Lee Feb. 9 th, 2007.
Impact of Anticoagulant and Anti-platelet Therapy on ICD Implant-Related Bleeding and Thromboembolic Events in Patients Enrolled in the NCDR ® ICD Registry.
Implantable Cardioverter Defibrillators to Prevent Sudden Cardiac Death: Background Frederick A. Masoudi, MD, MSPH Associate Professor of Medicine (Cardiology)
Gillian D Sanders Ph.D.Lurdes Y Inoue Ph.D. Associate Professor of MedicineAssociate Professor of Biostatistics Duke UniversityUniversity of Washington.
INTRODUCTION TO PRACTICE BASED RESEARCH
Documentation for Acute Care
CP ICD Registry Background – Current – Next Steps.
Clinical Effectiveness of Implantable Cardioverter-Defibrillators Among Medicare Beneficiaries With Heart Failure Adrian F. Hernandez, MD, MHS; Gregg.
CHARM-Preserved: Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity - Preserved Purpose To determine whether the angiotensin.
Clinical Trials. What is a clinical trial? Clinical trials are research studies involving people Used to find better ways to prevent, detect, and treat.
Overview Public Reporting Cardiovascular Data Recommendations.
Clinical Characteristics and Outcomes of Elderly Patients Treated With ICD and CRTD in Real World Setting: Data From the Israeli ICD Registry M. Suleiman,
Informing Public Policy to Address Health Care Disparities Boisey Barnes, MD, F.A.C.C. Founding Member and Trustee Association of Black Cardiologists.
Eliminating Health Disparities: Challenges and Opportunities Marsha Lillie-Blanton, Dr.P.H. Vice President in Health Policy The Henry J. Kaiser Family.
Author Disclosures Differences in Implantation-Related Adverse Events Between Men and Women Receiving ICD Therapy for Primary Prevention Differences in.
Coverage with Evidence Development Implantable Cardioverter Defibrillators 1 Sean Tunis MD, MSc June 23, 2009.
1 Sex/Gender and Minority Inclusion in NIH Clinical Research What Investigators Need to Know! Presenter: Miriam F. Kelty, PhD, National Institute on Aging,
Comparison of the American and Australian Health Care Systems By Emma Dougall, Emily Josef, Christie Felber and Hamed Al - Yahmedy.
CMS as a Public Health Agency: Effective Health Care Research Barry M. Straube, M.D. Centers for Medicare & Medicaid Services January 11, 2006.
CPORT- E Trial Randomized trial comparing outcomes of non-primary PCI at hospitals with and without on-site cardiac surgery.
Quality Measurement and Gender Differences in Managed Care Populations with Chronic Diseases Ann F. Chou Carol Weisman Arlene Bierman Sarah Hudson Scholle.
Healthy People 2010 Focus Area 1 Access to Quality Health Services Progress Review June 4, 2002.
ACTION Registry. Objectives of the NCDR Registries Provide data standardization Provide data that is –Relevant, Credible, Timely, Actionable Present real.
BEST: Beta-blocker Evaluation Survival Trial Purpose To determine whether the β-blocker bucindolol reduces morbidity and mortality in patients with advanced.
Acute Lead Dislodgements in NCDR ® ICD Registry™ Patients Alan Cheng, MD, Yongfei Wang, MS, Jeptha P. Curtis, MD, Paul D. Varosy, MD Johns Hopkins University.
Bleeding in Patients Undergoing Percutaneous Coronary Interventions: A Risk Model From 302,152 Patients in the NCDR. Sameer K. Mehta MD, Andrew D. Frutkin.
CP CathPCI Registry 10 Years and We Keep Going.
COMET: Carvedilol Or Metoprolol European Trial Purpose To compare the effects of carvedilol (a β 1 -, β 2 - and α 1 -receptor blocker) and short-acting.
Is the conscientious explicit and judicious use of current best evidence in making decision about the care of the individual patient (Dr. David Sackett)
NCDR Registry Statistics End of 4th Quarter 2011 Registry # of Participants # of Patient Records # of Manuscripts/ Abstracts ACTION Registry®- GWTG TM.
Healthy People 2010 Focus Area 1: Access to Quality Health Services Progress Review June 15, 2006.
Presentation Developed for the Academy of Managed Care Pharmacy
R1 강민혜 / prof. 전숙. Introduction Patients with type 2 diabetes have a greatly increased risk of cardiovascular events. The morbidity and mortality related.
Author Disclosure Sex Differences in the Characteristics of Patients Receiving ICD Therapy for the Primary Prevention of Sudden Cardiac Death –Stacie L.
Intersecting roles CMS and FDA – implications for pharmaceutical and device industries Peter B. Bach, MD, MAPP Senior Adviser, Office of the Administrator.
How Do We Individualize Guidelines in an Era of Personalized Medicine? Douglas K. Owens, MD, MS VA Palo Alto Health Care System Stanford University, Stanford.
Randomized vs. Observational Studies: Strengths and Weaknesses
Quality Health Care Nursing 870
Public Reporting of Cardiovascular Data
The EP Show: CMS reimbursement decision for ICDs
Atlantic Cardiovascular Patient Outcomes Research Team
Presentation transcript:

Heart Rhythm 2008 San Francisco May 15, 2008 Stephen Hammill, MD Heart Rhythm 2008 San Francisco May 15, 2008 Stephen Hammill, MD CP Using the ICD Registry to Evaluate Practice Patterns and Improve Quality Overview of the Development of the ICD Registry

ICD Registry Highlights to Date CP ,490 hospitals >260,000 implants (+10,000/month) 55% are primary prevention CMS patients 88% of implants from hospitals entering all patients (1° and 2° prevention, all ages) Version 2.0 in development Longitudinal registry developed (CED) Research and publications in progress 1,490 hospitals >260,000 implants (+10,000/month) 55% are primary prevention CMS patients 88% of implants from hospitals entering all patients (1° and 2° prevention, all ages) Version 2.0 in development Longitudinal registry developed (CED) Research and publications in progress Getting to this point and moving forward

ICD Registry Developing the Baseline Registry CP /28/04: CMS published proposed NCD Following SCD-HeFT release National data base proposed HRS asked to chair the Working Group to develop the registry 9/28/04: CMS published proposed NCD Following SCD-HeFT release National data base proposed HRS asked to chair the Working Group to develop the registry

National ICD Registry Working Group HRS, chair ACC HFSAAHA MedtronicBiotronik GuidantSt Jude BCBSNCDR United HealthCareAetna Am Hlth Ins PlansAHRQ FDAAm Hosp Assoc CMSAt large members HRS, chair ACC HFSAAHA MedtronicBiotronik GuidantSt Jude BCBSNCDR United HealthCareAetna Am Hlth Ins PlansAHRQ FDAAm Hosp Assoc CMSAt large members

ICD Registry Developing the Baseline Registry CP /28/04: CMS published proposed NCD Following SCD-HeFT release National data base proposed HRS asked to chair the Working Group to develop the registry 11/22/04: Working Group recommendations sent to CMS Purpose of the registry Patients to be enrolled Patient and device data elements to be collected Defining providers as competent and qualified to implant ICDs 9/28/04: CMS published proposed NCD Following SCD-HeFT release National data base proposed HRS asked to chair the Working Group to develop the registry 11/22/04: Working Group recommendations sent to CMS Purpose of the registry Patients to be enrolled Patient and device data elements to be collected Defining providers as competent and qualified to implant ICDs

ICD Registry Developing the Baseline Registry CP /27/05: CMS published final NCD Expanded ICD indications CED process described Data collection using QNet Temporary data collection tool 1/27/05: CMS published final NCD Expanded ICD indications CED process described Data collection using QNet Temporary data collection tool

What does CMS hope to gain from the Registry? CMSs goal is to determine whether primary prevention ICDs are appropriate for the Medicare beneficiaries who meet the clinical conditions identified in the agencies NCD of 1/27/05. Coverage with evidence development (CED) Hammill, Phurrough, Brindis. HeartRhythm, 2006

CED Coverage with evidence development Develop evidence on what works best in clinical practice... explicit, rapid, evidence based on a process that is predictable with transparency... to improve the knowledge base by which patients and providers can make better treatment decisions. Mark McClellan Administrator, CMS 2/14/05 Conference call

ICD Registry Developing the Baseline Registry CP /27/05: CMS published final NCD Expanded indications CED process described Data collection using QNet Temporary data collection tool 3/05: HRS asked to reconvene the Working Group Define questions that should be answered Define the core characteristics of a national clinical registry 5/19/05: Recommendations sent to CMS 1/27/05: CMS published final NCD Expanded indications CED process described Data collection using QNet Temporary data collection tool 3/05: HRS asked to reconvene the Working Group Define questions that should be answered Define the core characteristics of a national clinical registry 5/19/05: Recommendations sent to CMS

ICD Registry Developing the Baseline Registry CP /27/05: CMS selected the ICD Registry developed by ACC and HRS based on the NCDR

ICD Registry Developing the Baseline Registry CP /27/05: CMS selected the ICD Registry developed by ACC and HRS based on the NCDR 1/1/06: All data submitted to ICD Registry; QNet phased out 4/1/06 Hospitals encouraged to submit data on all patients SCD-HeFT – median age 60 yrs Medicare – median age 74 yrs 10/27/05: CMS selected the ICD Registry developed by ACC and HRS based on the NCDR 1/1/06: All data submitted to ICD Registry; QNet phased out 4/1/06 Hospitals encouraged to submit data on all patients SCD-HeFT – median age 60 yrs Medicare – median age 74 yrs

ICD Registry Developing the Baseline Registry CP /27/05: CMS selected the ICD Registry developed by ACC and HRS based on the NCDR 1/1/06: All data submitted to ICD Registry; QNet phased out 4/1/06 Hospitals encouraged to submit data on all patients SCD-HeFT – median age 60 yrs Medicare – median age 74 yrs 4/07: Quarterly benchmarking reports sent to hospitals Data Quality Reporting process Random auditing 10/27/05: CMS selected the ICD Registry developed by ACC and HRS based on the NCDR 1/1/06: All data submitted to ICD Registry; QNet phased out 4/1/06 Hospitals encouraged to submit data on all patients SCD-HeFT – median age 60 yrs Medicare – median age 74 yrs 4/07: Quarterly benchmarking reports sent to hospitals Data Quality Reporting process Random auditing

ICD Registry Data Quality Program National Onsite Audit Program Annual review 10% random sample of eligible sites Comparative analysis of audit findings and sites original data submission (MD training discrepancy, lack of complications, etc) National Onsite Audit Program Annual review 10% random sample of eligible sites Comparative analysis of audit findings and sites original data submission (MD training discrepancy, lack of complications, etc)

Why is Benchmarking Important to Hospitals? Quarterly benchmarking compares a hospitals outcomes with hospitals of similar size and a national aggregate Improved Patient Care Meet State Regulations and Payer Requirements Detect Inefficiencies Improved resource utilization Quarterly benchmarking compares a hospitals outcomes with hospitals of similar size and a national aggregate Improved Patient Care Meet State Regulations and Payer Requirements Detect Inefficiencies Improved resource utilization

Potential Benefits of the Registry Reveal the degree to which clinicians are managing a disease in accordance with evidence-based medicine Enable clinicians to compare their own outcomes with those of other MDs Provide insights for clinical investigation Highlight a products performance outside of clinical trial constraints Reveal the degree to which clinicians are managing a disease in accordance with evidence-based medicine Enable clinicians to compare their own outcomes with those of other MDs Provide insights for clinical investigation Highlight a products performance outside of clinical trial constraints Hammill, Phurrough, Brindis. HeartRhythm, 2006

Potential Benefits of the Registry Provide a detailed view of the morbidity, mortality, and resource utilization associated with a particular disease Perform local hospital needs for QA and QI Serve as a hospital and physician response to Pay for Performance initiatives of health plans Provide a detailed view of the morbidity, mortality, and resource utilization associated with a particular disease Perform local hospital needs for QA and QI Serve as a hospital and physician response to Pay for Performance initiatives of health plans Hammill, Phurrough, Brindis. HeartRhythm, 2006

ICD Registry A Quality Improvement Tool AHRQ CP Observational registries can quickly accumulate large amounts of data on real- world practice and effectiveness of new treatments and procedures. Physicians and hospitals can use these data to further QI efforts at a local level and physician associations can evaluate data to determine the effectiveness of existing clinical guidelines. Registries for Evaluating Patient Outcomes: A Users Guide. A Users Guide. Agency for Health Care Research and Quality Agency for Health Care Research and Quality

National ICD Registry 2006 CP Age (yr)68 Male/female (%)74/26 Race (%) White83 Black/African American12 Hispanic 5 Asian 1 American Indian/Alaska Native 0.4 Native Hawaiian 0.2 Other 4 Age (yr)68 Male/female (%)74/26 Race (%) White83 Black/African American12 Hispanic 5 Asian 1 American Indian/Alaska Native 0.4 Native Hawaiian 0.2 Other 4 Hammill et al: Heart Rhythm, 2007

National ICD Registry 2006 CP Hammill et al: Heart Rhythm, 2007 Total implants (no.)206,604 Hypertension (%) 74 Diabetes (%) 36 Chronic lung disease (%) 22 Ischemic heart disease (%) 66 Non-ischemic dilated cardiomyopathy (%) 31 Hx of cardiac arrest (%) 11 Hx of CHF, no. (%) 77 NYHA class II-III (%) 81 QRS duration (ms) 129 Ejection fraction (%) 28 Total implants (no.)206,604 Hypertension (%) 74 Diabetes (%) 36 Chronic lung disease (%) 22 Ischemic heart disease (%) 66 Non-ischemic dilated cardiomyopathy (%) 31 Hx of cardiac arrest (%) 11 Hx of CHF, no. (%) 77 NYHA class II-III (%) 81 QRS duration (ms) 129 Ejection fraction (%) 28

National ICD Registry 2006 CP Total implants (no.) 108,341 Single chamber ICD (%) 23 Dual chamber ICD (%) 39 Biventricular ICD (%) 38 Adverse procedure-related event (%) 3.24 Death in laboratory 0.02 Cardiac perforation 0.07 Hematoma 0.99 Lead dislodgement 0.97 Hemo/pneumothorax 0.54 Transient ischemic attack/stroke 0.06 Other 0.61 Total implants (no.) 108,341 Single chamber ICD (%) 23 Dual chamber ICD (%) 39 Biventricular ICD (%) 38 Adverse procedure-related event (%) 3.24 Death in laboratory 0.02 Cardiac perforation 0.07 Hematoma 0.99 Lead dislodgement 0.97 Hemo/pneumothorax 0.54 Transient ischemic attack/stroke 0.06 Other 0.61 Hammill et al: Heart Rhythm, 2007

National ICD Registry 2006 CP Hammill et al: Heart Rhythm, 2007 Physicians % Implants performed % Training category EP fellowship + boards EP fellowship only 6 6 Surgery residency 11 2 HRS ICD Guidelines 17 9 None of the above 15 6 Training category EP fellowship + boards EP fellowship only 6 6 Surgery residency 11 2 HRS ICD Guidelines 17 9 None of the above ,899 implanting physicians 206,604 procedures 206,604 procedures

Are payors and providers adversaries or partners? adversaries or partners?

Hospital and PhysicianProfiling CMS Health Plans State and Federal Lawmakers State Departments Of Health Patients And Families Insurers

Administrative data versus Clinical data

CP Conclusions – Cardiac surgery report cards using administrative data are problematic compared with those derived from audited and validated clinical data, primarily because of case misclassification and nonstandarized end points.

FL MA O O NJ CA MD IL MI WV State Regulators Are Using the Cath NCDR® Regulation Passed Regulation Pending Regulation Passed Regulation Pending PA IA AL

Payers and the ICD Registry May 24, 2007: United Health Care, ACC and HRS announced an initiative that will improve patient care by expanding the collection and use of clinical outcomes data for heart rhythm devices by cardiac care facilities, cardiac surgeons, cardiologists, and other healthcare professionals Hospitals seeking designation as a United Health Premium Cardiac Specialty Center will be required to submit data to the National ICD Registry May 24, 2007: United Health Care, ACC and HRS announced an initiative that will improve patient care by expanding the collection and use of clinical outcomes data for heart rhythm devices by cardiac care facilities, cardiac surgeons, cardiologists, and other healthcare professionals Hospitals seeking designation as a United Health Premium Cardiac Specialty Center will be required to submit data to the National ICD Registry

Developing the Longitudinal Registry to Answer the CED Questions CP

It is particularly important that these factors (ICD firing data and survival) be determined in the actual population receiving ICDs, who are older and present more comorbidities than represented in the trial populations. Fortunately, these key factors will be tracked in the ICD Registry Lynne Warner Stevenson, MD Circulation. 2006;114:101

CED Questions EF 31-15% EF 31-15% Non-ischemic cardiomyopathy <9 months Non-ischemic cardiomyopathy <9 months Class IV CRT-D patients Class IV CRT-D patients EF 31-15% EF 31-15% Non-ischemic cardiomyopathy <9 months Non-ischemic cardiomyopathy <9 months Class IV CRT-D patients Class IV CRT-D patients

Longitudinal Registry Study Design CP Primary endpoint Primary endpoint First delivery of an appropriate ICD therapy (shock, ATP) Secondary endpoint Secondary endpoint Survival probability at 3 and 5 years Death from CV cause Total # and rate of device therapies Ratio of inappropriate to total device therapies Primary endpoint Primary endpoint First delivery of an appropriate ICD therapy (shock, ATP) Secondary endpoint Secondary endpoint Survival probability at 3 and 5 years Death from CV cause Total # and rate of device therapies Ratio of inappropriate to total device therapies

Longitudinal Registry Study Design CP randomly selected implanting MDs 350 randomly selected implanting MDs 3,500 patients followed 3 years for events and 5 years for survival 3,500 patients followed 3 years for events and 5 years for survival Based on 10% rate of appropriate therapy at 3 years (15% at 3 years in SCD-HeFT) Device therapy follow-up Device therapy follow-up Every 3 months for a minimum of 3 years Adjudication process Data combined with NDI and Medicare claims data 350 randomly selected implanting MDs 350 randomly selected implanting MDs 3,500 patients followed 3 years for events and 5 years for survival 3,500 patients followed 3 years for events and 5 years for survival Based on 10% rate of appropriate therapy at 3 years (15% at 3 years in SCD-HeFT) Device therapy follow-up Device therapy follow-up Every 3 months for a minimum of 3 years Adjudication process Data combined with NDI and Medicare claims data

ICD Registry Version 2.0 – Updating the Registry CP Redefine the registry purpose, target audience Enhance the data collection forms Add leads -- implant, revision, replacement Make the registry a performance reporting tool (Guidelines) Post market surveillance (FDA Sentinel Network) Coordinate with longitudinal data – Medicare Claims Data, National Death Index Redefine the registry purpose, target audience Enhance the data collection forms Add leads -- implant, revision, replacement Make the registry a performance reporting tool (Guidelines) Post market surveillance (FDA Sentinel Network) Coordinate with longitudinal data – Medicare Claims Data, National Death Index

ICD Registry Research and Publications CP Research requests are reviewed and prioritized by R&P Subcommittee 34+ requests to date ICD-Registry provides financial support for data analysis Yale CORE assists with data analysis 6 abstracts presented at AHA, 11/07 5 manuscripts Research requests are reviewed and prioritized by R&P Subcommittee 34+ requests to date ICD-Registry provides financial support for data analysis Yale CORE assists with data analysis 6 abstracts presented at AHA, 11/07 5 manuscripts

ICD Registry Research and Publications CP Sample research proposals How do the baseline characteristics of patients receiving ICD therapy in the general population (real world) compare with the characteristics of patients enrolled in randomized clinical trials of ICD therapy? Are patient outcomes such as morbidity and mortality affected by patient baseline clinical characteristics such as ejection fraction, QRS duration, NYHA class, gender, age, and race? Sample research proposals How do the baseline characteristics of patients receiving ICD therapy in the general population (real world) compare with the characteristics of patients enrolled in randomized clinical trials of ICD therapy? Are patient outcomes such as morbidity and mortality affected by patient baseline clinical characteristics such as ejection fraction, QRS duration, NYHA class, gender, age, and race?

ICD Registry Research and Publications CP Sample research proposals What are the characteristics of the physicians implanting ICDs regarding training, experience, and volume; and how does this relate to implantation outcomes? Does age, race, and sex distribution of patients undergoing ICD implantation differ among different regions of the country and different size of hospitals? Sample research proposals What are the characteristics of the physicians implanting ICDs regarding training, experience, and volume; and how does this relate to implantation outcomes? Does age, race, and sex distribution of patients undergoing ICD implantation differ among different regions of the country and different size of hospitals?

Why a Registry? Science tells us what we can do; Guidelines what we should do; and Registries what we are actually doing Science tells us what we can do; Guidelines what we should do; and Registries what we are actually doing. Lukas Kappenberger MD HRS ICD Policy Conference Washington DC, 9/16/05 Science tells us what we can do; Guidelines what we should do; and Registries what we are actually doing Science tells us what we can do; Guidelines what we should do; and Registries what we are actually doing. Lukas Kappenberger MD HRS ICD Policy Conference Washington DC, 9/16/05